Clinical Trials News
Market immunity? How public safety warnings have little impact on drug sales volumes or pharma company share prices
Under the system used by drug regulators in the US, Europe and elsewhere, drug companies need only show from clinical trials that new drugs have short-term safety and efficacy in order to gain approval
Arora said, "Very soon, mRNA vaccine is also coming. Based on international data, it is very encouraging that we can use that for children."
If approved, the two-dose vaccine will be given to children within 20 days apart.
In the US, anyone 12 and older is eligible for the vaccine but with the new variants and schools reopening, parents are wondering when younger children can get the shots.
The ICMR was designated as the nodal agency for the collection of vaccination data for such participants by the ministry.
Azerbaijan trial studying effects of combined Sputnik and AstraZeneca vaccines reports positive results
When contacted for their response to the latest development, both Serum Institute of India and Dr Reddy's Laboratories refused to comment at this time.
The study began in June 2021 and will continue till May 2022 and is being conducted in over 600 hospitals in 52 countries.
Vaccinated survivors can make antibodies that can recognize all kinds of variants even if you were never exposed to the variant.
The intranasal vaccine BBV154 is being tested to check if it prevents infection, halts person-to-person transmission, and progression of COVID-19.
Franz-Werner Haas, chief executive blamed the results on the high number of variants in the countries where the vaccine was tested.
Bharat Biotech's Covaxin trials on children between 2-18 years of age amounts to homicide: Plea in Delhi HC
Petitioner Sanjeev Kumar said the children could suffer adverse health or mental effects due to the vaccine testing.
The vaccine recently got the nod of approval for phase-3 clinical trials after showing promising results in phase 1 and 2.
Biological E will conduct a bridging trial for the vaccine in India and also manufacture the vaccine.
Niti Aayog member VK Paul has said that mixing COVID-19 vaccines is plausible, but "there need to be more studies."
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS Patna and Meditrina Institute of Medical Sciences, Nagpur.
In April, the US pharma company had offered a not-for-profit price for its vaccine for the Indian government's immunisation programme.
There have been no reports of cases in India, authorities are still looking into claims as many countries have either stopped or limited the use of the vaccine.
AstraZeneca's Britain COVID-19 vaccine clinical trials for children paused due to blood clot concerns
Britain and the vaccine's developers had until now resisted any restrictions in its use, saying that there was no proof of any link.
If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year.
Like anti-malaria drug hydroxychloroquine — so far unproven by clinical trials — ivermectin is widely available and cheap.